These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 17578049)

  • 41. Oral anticoagulation.
    Alexander C; Rana S
    J Fam Pract; 1996 Jan; 42(1):21. PubMed ID: 8537795
    [No Abstract]   [Full Text] [Related]  

  • 42. International normalized ratio patient self-management for mechanical valves: is it safe enough?
    Koerfer R; Reiss N; Koertke H
    Curr Opin Cardiol; 2009 Mar; 24(2):130-5. PubMed ID: 19532098
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Should we use anticoagulation for patients with chronic heart failure?
    Freudenberger RS; Halperin JL
    Nat Clin Pract Cardiovasc Med; 2006 Nov; 3(11):580-1. PubMed ID: 17063158
    [No Abstract]   [Full Text] [Related]  

  • 44. "Bridging on the river Kwai": the perioperative management of anticoagulation therapy.
    Eckman MH
    Med Decis Making; 2005; 25(4):370-3. PubMed ID: 16061888
    [No Abstract]   [Full Text] [Related]  

  • 45. Comparison of a chromogenic factor X assay with international normalized ratio for monitoring oral anticoagulation therapy.
    McGlasson DL; Romick BG; Rubal BJ
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):513-7. PubMed ID: 18685434
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Warfarin-associated fetal intracranial hemorrhage in woman with mitral valve replacements: a case report.
    Masamoto H; Uehara H; Mekaru K; Uezato T; Sakumoto K; Aoki Y
    Am J Perinatol; 2009 Sep; 26(8):597-600. PubMed ID: 19404899
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oral anticoagulation with antiplatelet therapy after drug-eluting stent placement: adequate INR control must be demonstrated.
    Murphy P
    J Intern Med; 2009 Jun; 265(6):725; author reply 726. PubMed ID: 19493062
    [No Abstract]   [Full Text] [Related]  

  • 48. Anticoagulation management in hip fracture patients on warfarin [Injury 2005;36:1311-5].
    Tharmarajah P
    Injury; 2006 Oct; 37(10):1029-30; author reply 1030-1. PubMed ID: 16934264
    [No Abstract]   [Full Text] [Related]  

  • 49. A practical approach for bridging anticoagulation after mechanical heart valve replacement.
    Steger V; Bail DH; Graf D; Walker T; Rittig K; Ziemer G
    J Heart Valve Dis; 2008 May; 17(3):335-42. PubMed ID: 18592932
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An evidence-based review and guidelines for patient self-testing and management of oral anticoagulation.
    Fitzmaurice DA; Gardiner C; Kitchen S; Mackie I; Murray ET; Machin SJ;
    Br J Haematol; 2005 Oct; 131(2):156-65. PubMed ID: 16197444
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Coagulation self-control after valve replacement. Stable anticoagulation permits lowering of the intensity].
    MMW Fortschr Med; 2004 Apr; 146(14):44. PubMed ID: 15344756
    [No Abstract]   [Full Text] [Related]  

  • 52. Failure of guideline-based anticoagulation in a patient with mitral prosthetic valve and recurrent thromboembolism.
    Mutlu H; Yerlioglu ME; Levy WK
    J Am Soc Echocardiogr; 2008 Mar; 21(3):296.e1-3. PubMed ID: 17681732
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Freedom from complications related to dual ball-and-cage mechanical valve prostheses despite thirty years without anticoagulation.
    Miller MM; Hipp R; Matsumura ME
    Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1167-9. PubMed ID: 18669529
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Low-intensity oral anticoagulant plus low-dose aspirin during the first six months versus standard-intensity oral anticoagulant therapy after mechanical heart valve replacement: a pilot study of low-intensity warfarin and aspirin in cardiac prostheses (LIWACAP).
    Pengo V; Palareti G; Cucchini U; Molinatti M; Del Bono R; Baudo F; Ghirarduzzi A; Pegoraro C; Iliceto S;
    Clin Appl Thromb Hemost; 2007 Jul; 13(3):241-8. PubMed ID: 17636186
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Understanding low INR in clinical practice.
    Hylek EM; Rose AJ
    Thromb Haemost; 2009 Mar; 101(3):417-8. PubMed ID: 19277399
    [No Abstract]   [Full Text] [Related]  

  • 56. Peri-procedural anticoagulation management of mechanical prosthetic heart valve patients.
    Daniels PR; McBane RD; Litin SC; Ward SA; Hodge DO; Dowling NF; Heit JA
    Thromb Res; 2009 Jul; 124(3):300-5. PubMed ID: 19232682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Importance of long-term anticoagulation in both prosthetic and biological tricuspid valve replacements.
    Rafiq I; Freeman LJ; Wood S
    Ann Thorac Surg; 2007 Oct; 84(4):1424; author reply 1425. PubMed ID: 17889027
    [No Abstract]   [Full Text] [Related]  

  • 58. Incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.
    Dentali F; Riva N; Malato A; Saccullo G; Siragusa S; Ageno W
    J Thorac Cardiovasc Surg; 2009 Jan; 137(1):91-3. PubMed ID: 19154909
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Challenges in managing anticoagulant therapy in patients with heart valve prostheses.
    Vink R; Kamphuisen PW; van den Brink RB; Levi M
    Expert Rev Cardiovasc Ther; 2007 May; 5(3):563-70. PubMed ID: 17489678
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association between prothrombin activation fragment (F1.2), cerebral ischemia (S-100beta) and international normalized ratio (INR) in patients with ventricular assisted devices.
    Joshi A; Magder LS; Kon Z; Kallam S; Kwon M; Sangrampurkar R; Pierson R; Poston R
    Interact Cardiovasc Thorac Surg; 2007 Jun; 6(3):323-7. PubMed ID: 17669856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.